PATENT CLAIM ANALYSIS

Application Number: 16151730
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["514", "298000"]

Abstract:
This invention relates to the use of low doses of (+)-α-dihydrotetrabenazine for the treatment of movement disorders, such as Tourette's syndrome.

Claim (Index 10):
A method according to  claim 6  wherein the treatment comprises the administration of a maximum (e.g. optimized) daily dosage of (+)-\u03b1-dihydrotetrabenazine or pharmaceutically acceptable salt thereof, which is an amount corresponding to no greater than 20 mg of (+)-\u03b1-dihydrotetrabenazine free base.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 97.0
- Lexical Diversity: 1.125
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15939826', '15939837', '12555695', '15116786', '14442996']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8194456676676692
- 35 USC 102 Novelty (BERT): 0.6162658721317514
- Combined Prediction Score: 0.7991276881140775
- Mean Citation Score: 432.914024
- Max Citation Score: 644.5441
- Similarity Product: 481.50431824253786

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test